Introduction A specialized Biosimilar Functional Bioassay Development Service provides Mechanism of Action (MoA)-reflective cell-based and binding assays that are specifically […]
Introduction The optimization of Purification Techniques for Peptide-Oligonucleotide Conjugates depends on the strategic application of orthogonal chromatographic methodologies capable of
Purification Techniques for Peptide-Oligonucleotide Conjugates (HPLC, Ion Exchange, SEC) Read More »
Introduction The decision to adopt a consolidated or split Drug Substance vs Drug Product CDMO model plays a pivotal role
Drug Substance vs Drug Product CDMO: Understanding the Split and When to Use Each Read More »
Introduction A comprehensive analytical data package prepared for an Investigational New Drug (IND) submission provides regulatory agencies with robust structural,
Introduction Peptide-oligonucleotide conjugates gain entry into cells mainly through energy-dependent endocytosis or energy-independent direct plasma membrane translocation, with the dominant
Introduction Obtaining approval for an Abbreviated New Drug Application (ANDA) from the U.S. Food and Drug Administration (FDA) requires manufacturers
Introduction: Peptide Characterization Services play a critical role in the successful development of biosimilars and complex peptide therapeutics. Regulatory agencies
Peptide Characterization Services for Biosimilar and Complex Drug Applications Read More »
Introduction Method Validation for Leachables Testing in a Good Manufacturing Practice (GMP) laboratory provides documented, objective evidence that an analytical
Method Validation for Leachables Testing: What Regulators Expect from a GMP Lab Read More »
